
News |
Shore Capital acts as Joint Bookrunner on £9.1m Conditional Placing & Open Offer of up to £2.9m for Oxford Biodynamics plc
Oxford BioDynamics (AIM:OBD) a biotechnology company developing targeted clinical diagnostic tests for immune health based on the EpiSwitch® 3D genomics […]